Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Mar 06, 2021 2:56pm
187 Views
Post# 32736745

Biden’s $1.9 trillion plan include $47.8 billion for Testing

Biden’s $1.9 trillion plan include $47.8 billion for TestingSenate passes Biden’s massive $1.9 trillion COVID stimulus plan in 50-49 party-line vote
 
Vaccines and testing
 
The Senate and House bills provide $14 billion to research, develop, distribute, administer and strengthen confidence in vaccines. They would also put $47.8 billion toward testing, contact tracing and mitigation, including investing in laboratory capacity, community-based testing sites and mobile testing units, particularly in medically underserved areas.
 
Both chambers would also allocate $7.7 billion to hire 100,000 public health workers to support coronavirus response.
 
The Senate and House legislation also provide $50 billion to the Federal Emergency Management Agency, with some of the funds going toward expanding vaccination efforts.
 
The President's plan called for investing $20 billion in a national vaccination program.
 
https://www.cnn.com/2021/03/04/politics/stimulus-senate-democrats-proposal/index.html

 
<< Previous
Bullboard Posts
Next >>